Clinical Trials Directory

Trials / Unknown

UnknownNCT00008788

Osteoporosis in Children and Adults Following Liver Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
40 (planned)
Sponsor
National Center for Research Resources (NCRR) · NIH
Sex
All
Age
16 Years – 40 Years
Healthy volunteers
Not accepted

Summary

This pilot project aims to 1) estimate the prevalence of osteoporosis in adults having undergone liver transplantation in childhood, and 2) identify risk factors for osteoporosis in this group. We aim to study 40 individuals.

Detailed description

Background: Osteoporosis is defined as an absolute decrease in the amount of bone (volume and/or density). Chronic liver disease is associated with osteoporosis in both adults and children. Bone density is also decreased in the months immediately after liver transplantation, but improves to pretransplant values after 1 to 2 years. Immunosuppressive agents, most notably steroids, are a cause of osteoporosis. However, studies on adults have shown that bone densities afer transplantation continue to improve within the normal range for healthy adults. In the case of children, bone accretion is necessary for growth. Chronic liver disease and transplantation in childhood will have an adverse effect on bone metabolism and the outcome in terms of bone density after the growth period cannot be predicted on individuals transplanted as adults or other transplant groups.

Conditions

Timeline

First posted
2001-01-18
Last updated
2005-06-24

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00008788. Inclusion in this directory is not an endorsement.